PIRS Stock Analysis Overview
What this means: Pieris Pharma (PIRS) gets an Overall Rank of 58, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. PIRS's 58 means that it ranks higher than 58% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
PIRS Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
PIRS Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
PIRS Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
PIRS Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
PIRS Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
PIRS Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
PIRS Stock Analysis Overview
What this means: Pieris Pharma (PIRS) gets an Overall Rank of 58, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. PIRS's 58 means that it ranks higher than 58% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.